N Keller

Feasibility of using recombinant factor VIIa in continuous infusion.

Sam Schulman, Michael Bech Jensen, D. Varon et al. · PubMed · 1996 · 107 citations

Medicine, Hematology, Pharmacology +13

Monoclonal Purified F VIII for Continuous Infusion: Stability, Microbiological Safety and Clinical Experience

Sam Schulman, D. Varon, N Keller et al. · Thrombosis and Haemostasis · 1994 · 57 citations

Medicine, Hematology, Pharmacology +17

Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease

Eyal Meltzer, Gill Smollan, Amit Huppert et al. · Clinical Microbiology and Infection · 2019 · 35 citations

Medicine, Infectious Diseases, Internal Medicine +17

Disinfection with 10% povidone‐iodine versus 0.5% chlorhexidine gluconate in 70% isopropanol in the neonatal intensive care unit

Nehama Linder, S. Prince, A Barzilai et al. · Acta Paediatrica · 2004 · 30 citations

Medicine, Infectious Diseases, Pediatrics +17

Intracellular survival of persistent Group A streptococci in cultured epithelial cells

Mehran J. Marouni, Asher Barzilai, N Keller et al. · International Journal of Medical Microbiology · 2004 · 24 citations

Life Sciences, Infectious Diseases, Microbiology +12